Sernova Corp. (OTCMKTS:SEOVF – Get Free Report) was the recipient of a large decline in short interest in February. As of February 15th, there was short interest totalling 3,200 shares, a decline of 98.7% from the January 31st total of 244,100 shares. Based on an average daily volume of 45,400 shares, the short-interest ratio is currently 0.1 days.
Sernova Stock Performance
Sernova stock opened at $0.14 on Friday. Sernova has a fifty-two week low of $0.12 and a fifty-two week high of $0.45. The stock has a market cap of $45.59 million, a P/E ratio of -2.31 and a beta of 1.16. The firm’s fifty day moving average price is $0.15 and its 200-day moving average price is $0.17.
Sernova (OTCMKTS:SEOVF – Get Free Report) last released its quarterly earnings results on Monday, December 23rd. The company reported ($0.01) earnings per share for the quarter.
Sernova Company Profile
Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.
Featured Stories
- Five stocks we like better than Sernova
- The How And Why of Investing in Oil Stocks
- Analysts Lift Archer Aviation Stock Despite Earnings Miss
- Best Stocks Under $5.00
- 5 Best Gold ETFs for March to Curb Recession Fears
- What Are Dividend Challengers?
- 3 Stocks for Your Watchlist: Unlocking Tomorrow’s Winners Today
Receive News & Ratings for Sernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova and related companies with MarketBeat.com's FREE daily email newsletter.
